Personal information

No personal information available

Activities

Collapse all

Employment (1)

Memorial Sloan Kettering Cancer Center: New York, US

2010-07 to present
Employment
Source: check_circle
Memorial Sloan Kettering Cancer Center

Works (20)

Tumor of unknown primary site

Psycho-Oncology. 3rd ed
2015 | Book chapter
DOI: 10.1093/med/9780199363315.003.0024
Contributors: Varghese, A. M.; Saltz, L. B.; Holland, J. C.; Breitbart, W. S.; Butow, P. N.; Jacobsen, P. B.; Loscalzo, M. J.; McCorkle, R.
Source: check_circle
Memorial Sloan Kettering Cancer Center

Chemotherapy for stage II colon cancer

Clinics in Colon and Rectal Surgery
2015-12-01 | Journal article
DOI: 10.1055/s-0035-1564430
Contributors: Varghese, A.
Source: check_circle
Memorial Sloan Kettering Cancer Center

Lurbinectedin (PM01183) in combination with paclitaxel (P) in patients (pts) with advanced solid tumors

European Journal of Cancer
2015-09-01 | Conference abstract
SOURCE-WORK-ID:

82677
Contributors: Garralda, E.; Stathis, A.; Drilon, A.; Boni, V.; Hyman, D.; Calvo, E.; Griguolo, G.; Makker, V.; Doger, B.; Canziani, L. et al.
Source: check_circle
Memorial Sloan Kettering Cancer Center

A phase I, first-in-human dose study of the dual PI3K/mTOR inhibitor LY3023414 (LY) in patients (pts) with advanced cancer

Journal of Clinical Oncology
2015-05-20 | Conference abstract
SOURCE-WORK-ID:

80517
Contributors: Moore, K. N.; Varghese, A. M.; Hyman, D. M.; Callies, S.; Lin, J.; Wacheck, V.; Pant, S.; Bauer, T. M.; Bendell, J. C.
Source: check_circle
Memorial Sloan Kettering Cancer Center

Dose escalation stage of a first-in-class phase I study of the novel oral ERK 1/2 kinase inhibitor BVD-523 (ulixertinib) in patients with advanced solid tumors

Journal of Clinical Oncology
2015-05-20 | Conference abstract
SOURCE-WORK-ID:

80459
Contributors: Infante, J. R.; Janku, F.; Tolcher, A. W.; Patel, M. R.; Sullivan, R. J.; Flaherty, K.; Carvajal, R. D.; Varghese, A. M.; Wong, D. J. L.; Sznol, M. et al.
Source: check_circle
Memorial Sloan Kettering Cancer Center

Oxaliplatin can be safely infused at a rate of 1mg/m(2)/min

Journal of Clinical Oncology
2015-05-20 | Conference abstract
SOURCE-WORK-ID:

80378
Contributors: Cercek, A.; Park, V.; Yaeger, R. D.; Reidy, D. L.; Kemeny, N. E.; Stadler, Z. K.; Segal, N. H.; Varghese, A. M.; Saltz, L.
Source: check_circle
Memorial Sloan Kettering Cancer Center

Phase I trial of the HSP-90 inhibitor PU-H71

Journal of Clinical Oncology
2015-05-20 | Conference abstract
SOURCE-WORK-ID:

80431
Contributors: Gerecitano, J. F.; Modi, S.; Rampal, R.; Drilon, A. E.; Fury, M. G.; Gounder, M. M.; Harding, J. J.; Hyman, D. M.; Varghese, A. M.; Voss, M. H. et al.
Source: check_circle
Memorial Sloan Kettering Cancer Center

Prospective identification of potentially actionable molecular alterations in cancers of unknown primary

Journal of Clinical Oncology
2015-05-20 | Conference abstract
SOURCE-WORK-ID:

80614
Contributors: Varghese, A. M.; Hyman, D. M.; Zehir, A.; Vakiani, E.; Klimstra, D. S.; Ladanyi, M.; Berger, M. F.; Solit, D. B.; Saltz, L.
Source: check_circle
Memorial Sloan Kettering Cancer Center

Prospective molecular analysis of small cell lung cancer (SCLC) using next generation sequencing (NGS)

Journal of Clinical Oncology
2015-05-20 | Conference abstract
SOURCE-WORK-ID:

80550
Contributors: Pietanza, M. C.; Won, H. H.; Rekhtman, N.; Wang, L.; Travis, W. D.; Krug, L. M.; Varghese, A. M.; Paik, P. K.; Riely, G. J.; Zakowski, M. F. et al.
Source: check_circle
Memorial Sloan Kettering Cancer Center

Using mutational load in next generation sequencing (NGS) to identify mismatch repair (MMR) deficiency in colorectal cancer (CRC)

Journal of Clinical Oncology
2015-05-20 | Conference abstract
SOURCE-WORK-ID:

80363
Contributors: Battaglin, F.; Stadler, Z. K.; Cercek, A.; Yaeger, R. D.; Segal, N. H.; Varghese, A. M.; Kemeny, N. E.; Weiser, M. R.; Garcia-Aguilar, J.; Shia, J. et al.
Source: check_circle
Memorial Sloan Kettering Cancer Center

Prospective molecular evaluation of small cell lung cancer (SCLC) utilizing the comprehensive mutation analysis program (MAP) at Memorial Sloan Kettering Cancer Center (MSKCC)

Annals of Oncology
2014-09-01 | Conference abstract
SOURCE-WORK-ID:

68783
Contributors: Krug, L. M.; Pietanza, M. C.; Varghese, A. M.; Won, H.; Wang, L.; Rekhtman, N.; Travis, W. D.; Litvak, A.; Paik, P. K.; Riely, G. J. et al.
Source: check_circle
Memorial Sloan Kettering Cancer Center

Advancing clinical oncology through genome biology and technology

Genome Biology
2014-08-07 | Journal article
DOI: 10.1186/s13059-014-0427-x
PMID: 25198155
PMC: PMC4281954
Contributors: Varghese, A. M.; Berger, M. F.
Source: check_circle
Memorial Sloan Kettering Cancer Center

Small-cell lung cancers in patients who never smoked cigarettes

Journal of Thoracic Oncology
2014-06-01 | Journal article
DOI: 10.1097/jto.0000000000000142
PMID: 24828667
PMC: PMC4199745
Contributors: Varghese, A. M.; Zakowski, M. F.; Yu, H. A.; Won, H. H.; Riely, G. J.; Krug, L. M.; Kris, M. G.; Rekhtman, N.; Ladanyi, M.; Wang, L. et al.
Source: check_circle
Memorial Sloan Kettering Cancer Center

Phase I trial of the hedgehog (Hh) inhibitor, LDE225, in combination with etoposide and cisplatin (EP) for initial treatment of extensive stage small cell lung cancer (ES-SCLC)

Journal of Clinical Oncology
2014-05-20 | Conference abstract
SOURCE-WORK-ID:

81017
Contributors: Pietanza, M. C.; Krug, L. M.; Varghese, A. M.; Fleisher, M.; Teitcher, J. B.; Holodny, A.; Sima, C. S.; Litvak, A. M.; Ng, K. K.; Patel, P. R. et al.
Source: check_circle
Memorial Sloan Kettering Cancer Center

Lungs don't forget: Comparison of the KRAS and EGFR mutation profile and survival of collegiate smokers and never smokers with advanced lung cancers

Journal of Thoracic Oncology
2013 | Journal article
DOI: 10.1097/JTO.0b013e31827914ea
PMID: 23242442
PMC: PMC3534987
Contributors: Varghese, A. M.; Sima, C. S.; Chaft, J. E.; Johnson, M. L.; Riely, G. J.; Ladanyi, M.; Kris, M. G.
Source: check_circle
Memorial Sloan Kettering Cancer Center

Pemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancer

Annals of Oncology
2013 | Journal article
DOI: 10.1093/annonc/mds242
PMID: 22887466
PMC: PMC3525134
Contributors: Shaw, A. T.; Varghese, A. M.; Solomon, B. J.; Costa, D. B.; Novello, S.; Mino-Kenudson, M.; Awad, M. M.; Engelman, J. A.; Riely, G. J.; Monica, V. et al.
Source: check_circle
Memorial Sloan Kettering Cancer Center

Pilot trial of an adjuvant pentavalent vaccine for patients with small cell lung cancer (SCLC)

Journal of Thoracic Oncology
2013-11-01 | Conference abstract
SOURCE-WORK-ID:

65582
Contributors: Krug, L. M.; Varghese, A.; Ragupathi, G.; George, C.; Sawada, R.; Scholz, W. W.; Hansen, D.; Livingston, P. O.; Delasos, L.; Pietanza, M. C.
Source: check_circle
Memorial Sloan Kettering Cancer Center

Prospective molecular evaluation of small cell lung cancer (SCLC) utilizing the comprehensive mutation analysis Program at Memorial Sloan-Kettering Cancer Center (MSKCC)

Journal of Thoracic Oncology
2013-11-01 | Conference abstract
SOURCE-WORK-ID:

65609
Contributors: Pietanza, M. C.; Varghese, A.; Won, H.; Rekhtman, N.; Wang, L.; Travis, W. D.; Paik, P. K.; Riely, G. J.; Zakowski, M. F.; Ladanyi, M. et al.
Source: check_circle
Memorial Sloan Kettering Cancer Center

ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: An analysis of 1,683 patients with non-small cell lung cancer

Clinical Cancer Research
2013-08-01 | Journal article
DOI: 10.1158/1078-0432.ccr-13-0318
PMID: 23729361
PMC: PMC3874127
Contributors: Gainor, J. F.; Varghese, A. M.; Ou, S. H. I.; Kabraji, S.; Awad, M. M.; Katayama, R.; Pawlak, A.; Mino-Kenudson, M.; Yeap, B. Y.; Riely, G. J. et al.
Source: check_circle
Memorial Sloan Kettering Cancer Center

Response to erlotinib in patients with EGFR mutant advanced non-small cell lung cancers with a squamous or squamous-like component

Molecular Cancer Therapeutics
2012-11-01 | Journal article
DOI: 10.1158/1535-7163.mct-12-0163
PMID: 22896669
PMC: PMC3640858
Contributors: Paik, P. K.; Varghese, A. M.; Sima, C. S.; Moreira, A. L.; Ladanyi, M.; Kris, M. G.; Rekhtman, N.
Source: check_circle
Memorial Sloan Kettering Cancer Center

Peer review (2 reviews for 2 publications/grants)

Review activity for British journal of cancer. (1)
Review activity for HPB. (1)
How many people are using ORCID?